High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 12, 2013, Pages 1191-1195

  Singh, Ajeet B ^a,b   Bousman, Chad A ^b,c,d   Ng, Chee H ^b   Berk, Michael ^a,b,d,e  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

antidepressant; Child abuse; major depression; suicidality

Indexed keywords

ESCITALOPRAM; VENLAFAXINE;

ADULT; ARTICLE; CHILD ABUSE; DISEASE SEVERITY; HUMAN; IMPACT OF EVENTS SCALE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; RATING SCALE; REASONS FOR LIVING SCALE; SUICIDE;

ANTIDEPRESSANT; CHILD ABUSE; MAJOR DEPRESSION; SUICIDALITY;

ADULT; ADULT SURVIVORS OF CHILD ABUSE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; RISK FACTORS; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 84889022870     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413510212     Document Type: Article

References (36)

1. Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34-38 years. Journal of Affective Disorders. 2002 ; 68: 167-181
2. Barbui C, Esposito E, Cipriani A. Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Canadian Medical Association Journal. 2009 ; 180: 291-297
3. Beasley CM, Dornseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ. 1991 ; 303: 685-692
4. Berk M, Dodd S. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?. Medical Hypotheses. 2005 ; 65: 39-43
5. Berk M, Dodd S, Callaly P, et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. Journal of Affective Disorders. 2007 ; 103: 181-186
6. Berk M, Dodd S, Malhi GS. "Bipolar missed states": the diagnosis and clinical salience of bipolar mixed states. Australian and New Zealand Journal of Psychiatry. 2005 ; 39: 215-221
7. Chaffin M, Shultz SK. Psychometric evaluation of the Children's Impact of Traumatic Events Scale-Revised*. Child Abuse & Neglect. 2001 ; 25: 401-411
8. Conte JR, Schuerman JR. Factors associated with an increased impact of child sexual abuse. Child Abuse & Neglect. 1987 ; 11: 201-211
9. Everill J, Waller G. Disclosure of sexual abuse and psychological adjustment in female undergraduates. Child Abuse & Neglect. 1995 ; 19: 93-100
10. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. Journal of the American Medical Association. 2010 ; 303: 47-53
11. Gibbons RD, Brown CH, Hur K, et al. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. American Journal of Psychiatry. 2007 ; 164: 1044-1049
12. Gunnell D, Saperia J, Ashby D. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ. 2005 ; 330: 385
13. Hanson RF, Resnick HS, Saunders BE, et al. Factors related to the reporting of childhood rape. Child Abuse & Neglect. 1999 ; 23: 559-569
14. Johnson JG, Smailes EM, Cohen P, et al. Associations between four types of childhood neglect and personality disorder symptoms during adolescence and early adulthood: findings of a community-based longitudinal study. Journal of Personality Disorders. 2000 ; 14: 171-187
15. Katz LY, Kozyrskyj AL, Prior HJ, et al. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. Canadian Medical Association Journal. 2008 ; 178: 1005-1011
16. Khan A, Khan S, Kolts R, et al. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. American Journal of Psychiatry. 2003 ; 160: 790-792
17. Kraus JE, Horrigan JP, Carpenter DJ, et al. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. Journal of Affective Disorders. 2010 ; 120: 40-47
18. Leon AC, Solomon D a, Li C, et al. Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. Journal of Clinical Psychiatry. 2011 ; 72: 580-586
19. Libby AM, Orton HD, Valuck RJ. Persisting decline in depression treatment after FDA warnings. Archives of General Psychiatry. 2009 ; 66: 633-639
20. McNulty C, Wardle J. Adult disclosure of sexual abuse: a primary cause of psychological distress?. Child Abuse & Neglect. 1994 ; 18: 549-555
21. Mitchell J, Trangle M, Degnan B, et al Institute for clinical systems improvement ; 2013 2013 :
22. Morgan OWC, Griffiths C, Majeed A. Association between mortality from suicide in England and antidepressant prescribing: an ecological study. BMC Public Health. 2004 ; 4: 63
23. Nakagawa A, Grunebaum MF, Ellis SP, et al. Association of suicide and antidepressant prescription rates in Japan, 1999-2003. Journal of Clinical Psychiatry. 2007 ; 68: 908-916
24. Nanni V, Uher R, Danese A. Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. American Journal of Psychiatry. 2012 ; 169: 141-151
25. Olfson M, Marcus SC, Druss BG. Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Archives of General Psychiatry. 2008 ; 65: 94-101
26. Roesler TA. Reactions to disclosure of childhood sexual abuse. The effect on adult symptoms. Journal of Nervous and Mental Disease. 1994 ; 182: 618-624
27. Roesler TA, Wind TW. Telling the secret: Adult women describe their disclosures of incest. Journal of Interpersonal Violence. 1994 ; 9: 327-338
28. Silverman AB, Reinherz HZ, Giaconia RM. The long-term sequelae of child and adolescent abuse: a longitudinal community study. Child Abuse & Neglect. 1996 ; 20: 709-723
29. Simon GE, Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. American Journal of Psychiatry. 2007 ; 164: 1029-1034
30. Simon GE, Savarino J, Operskalski B, et al. Suicide risk during antidepressant treatment. American Journal of Psychiatry. 2006 ; 163: 41-47
31. Singh A B, Bousman C A, Ng CH, et al. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression. Translational Psychiatry. 2012 ; 2: e198
32. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009 ; 339: b2880
33. Sundin EC, Horowitz MJ. Impact of Event Scale: psychometric properties. British Journal of Psychiatry. 2002 ; 180: 205-209
34. Teicher MH, Glod C, Cole JO. Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry. 1990 ; 147: 207-210
35. Ullman SE. Social reactions to child sexual abuse disclosures: a critical review. Journal of Child Sexual Abuse. 2003 ; 12: 89-121
36. Winsper C, Zanarini M, Wolke D. Prospective study of family adversity and maladaptive parenting in childhood and borderline personality disorder symptoms in a non-clinical population at 11 years. Psychological Medicine. 2012 ; 5: 1-16